Prognostic impact of perioperative CA-125 levels in patients with endometrial cancer.

被引:0
|
作者
Tong, S. Y.
Lee, J.
Lee, J.
Kim, J. W.
Cho, C.
Kim, S.
Park, S.
Park, C.
Kim, K.
机构
[1] Kyung Hee Univ Hosp Gangdong, Seoul, South Korea
[2] Korea Univ, Coll Med, Seoul 136705, South Korea
[3] Seoul Natl Univ, Seoul, South Korea
[4] Keimyung Univ, Dongsan Med Ctr, Taegu, South Korea
[5] Chonnam Natl Univ, Kwangju, South Korea
[6] Natl Canc Ctr, Res Inst & Hosp, Goyang, South Korea
[7] Gachon Univ Gil Hospita, Inchon, South Korea
[8] Inje Univ, Busan Paik Hosp, Pusan, South Korea
关键词
D O I
10.1200/jco.2011.29.15_suppl.e15573
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e15573
引用
收藏
页数:1
相关论文
共 50 条
  • [21] The prognostic value of pretherapeutic tetranectin and CA-125 in patients with relapse of ovarian cancer
    Deng, XH
    Hogdall, EVS
    Hogdall, CK
    Norgaard-Pedersen, B
    Jorgensen, M
    Nielsen, H
    Engelholm, SAA
    GYNECOLOGIC ONCOLOGY, 2000, 79 (03) : 416 - 419
  • [22] CA-125 LEVELS IN ENDOMETRIOSIS
    PATTON, PE
    FIELD, CS
    HARMS, RW
    COULAM, CB
    FERTILITY AND STERILITY, 1986, 45 (06) : 770 - 773
  • [23] The prognostic role of preoperative serum CA 125 levels in patients with endometrial carcinoma
    Nikolaou, Marinos
    Kourea, Helen P.
    Tzelepi, Vasiliki
    Adonakis, Georgios
    Scopa, Chrisoula D.
    Tsapanos, Vasilios
    Kardamakis, Dimitrios
    Kalofonos, Charalambos
    Decavalas, Georgios
    JOURNAL OF BUON, 2014, 19 (01): : 198 - 202
  • [24] Preoperative serum levels of YKL 40 and CA125 as a prognostic indicators in patients with endometrial cancer
    Kotowicz, Beata
    Fuksiewicz, Malgorzata
    Jonska-Gmyrek, Joanna
    Wagrodzki, Michal
    Kowalska, Maria
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2017, 215 : 141 - 147
  • [25] Utility of HE4 and CA-125 as predictive and prognostic factors in preoperative assessment of endometrial cancer
    Gao, M.
    Zhang, N.
    Gao, Y.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 164 - 164
  • [26] CA-125/CEA RATIO AS A PROGNOSTIC FACTOR IN TYPE II ENDOMETRIAL CANCER: A SINGLE INSTITUTE EXPERIENCE
    Karadag, I
    Karakaya, S.
    Ates, O.
    Oksuzoglu, O. B. Cakmak
    WORLD CANCER RESEARCH JOURNAL, 2022, 9
  • [27] PERIPHERAL CA-125 LEVELS IN PATIENTS WITH UTERINE FIBROIDS
    BISCHOF, P
    GALFETTI, MA
    SEYDOUX, J
    VONHOSPENTHAL, JU
    CAMPANA, A
    HUMAN REPRODUCTION, 1992, 7 (01) : 35 - 38
  • [28] CA-125 SERUM LEVELS IN PATIENTS WITH PELVIC INFECTIONS
    FUITH, LC
    CZARNECKI, M
    JOURNAL OF TUMOR MARKER ONCOLOGY, 1995, 10 (02): : 93 - 95
  • [29] Serum CA-125 levels in the context of ProMisE molecular classification provide preoperative prognostic information that can direct endometrial cancer management
    Neilson, Andrea
    Jamieson, Amy
    Chiu, Derek
    Leung, Samuel
    Talhouk, Aline
    McAlpine, Jessica
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S190 - S191
  • [30] Normalization of CA-125 levels in patients with ovarian cancer undergoing intraperitoneal chemotherapy
    McBee, W. C.
    Richard, S. D.
    Seamon, L. G.
    Lesnock, J.
    O'Malley, D. M.
    Richardson, D. L.
    Krivak, T. C.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S144 - S144